Literature DB >> 22202456

Cdx2 controls expression of the protocadherin Mucdhl, an inhibitor of growth and β-catenin activity in colon cancer cells.

Isabelle Hinkel1, Isabelle Duluc, Elisabeth Martin, Dominique Guenot, Jean-Noel Freund, Isabelle Gross.   

Abstract

BACKGROUND & AIMS: The intestine-specific homeobox transcription factor Cdx2 is an important determinant of intestinal identity in the embryonic endoderm and regulates the balance between proliferation and differentiation in the adult intestinal epithelium. Human colon tumors often lose Cdx2 expression, and heterozygous inactivation of Cdx2 in mice increases colon tumorigenesis. We sought to identify Cdx2 target genes to determine how it contributes to intestinal homeostasis.
METHODS: We used expression profiling analysis to identify genes that are regulated by Cdx2 in colon cancer cells lines. Regulation and function of a potential target gene were further investigated using various cell assays.
RESULTS: In colon cancer cell lines, Cdx2 directly regulated the transcription of the gene that encodes the protocadherin Mucdhl. Mucdhl localized to the apex of differentiated cells in the intestinal epithelium, and its expression was reduced in most human colon tumors. Overexpression of Mucdhl inhibited low-density proliferation of colon cancer cells and reduced tumor formation in nude mice. One isoform of Mucdhl interacted with β-catenin and inhibited its transcriptional activity.
CONCLUSIONS: The transcription factor Cdx2 activates expression of the protocadherin Mucdhl, which interacts with β-catenin and regulates activities of intestinal cells. Loss of Cdx2 expression in colon cancer cells might reduce expression of Mucdhl and thereby lead to tumor formation.
Copyright © 2012 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22202456     DOI: 10.1053/j.gastro.2011.12.037

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  20 in total

Review 1.  Extending the functions of the homeotic transcription factor Cdx2 in the digestive system through nontranscriptional activities.

Authors:  Jean-Noël Freund; Isabelle Duluc; Jean-Marie Reimund; Isabelle Gross; Claire Domon-Dell
Journal:  World J Gastroenterol       Date:  2015-02-07       Impact factor: 5.742

Review 2.  Beyond E-cadherin: roles of other cadherin superfamily members in cancer.

Authors:  Frans van Roy
Journal:  Nat Rev Cancer       Date:  2014-01-20       Impact factor: 60.716

3.  Transcriptional regulation of the intestinal nuclear bile acid farnesoid X receptor (FXR) by the caudal-related homeobox 2 (CDX2).

Authors:  Salvatore Modica; Marica Cariello; Annalisa Morgano; Isabelle Gross; Maria Carmela Vegliante; Stefania Murzilli; Lorena Salvatore; Jean-Noel Freund; Carlo Sabbà; Antonio Moschetta
Journal:  J Biol Chem       Date:  2014-08-19       Impact factor: 5.157

4.  Distinct patterns of DNA methylation in conventional adenomas involving the right and left colon.

Authors:  Devin C Koestler; Jing Li; John A Baron; Gregory J Tsongalis; Lynn F Butterly; Martha Goodrich; Corina Lesseur; Margaret R Karagas; Carmen J Marsit; Jason H Moore; Angeline S Andrew; Amitabh Srivastava
Journal:  Mod Pathol       Date:  2013-07-19       Impact factor: 7.842

5.  Cdx2 Regulates Intestinal EphrinB1 through the Notch Pathway.

Authors:  Yalun Zhu; Alexa Hryniuk; Tanya Foley; Bradley Hess; David Lohnes
Journal:  Genes (Basel)       Date:  2021-01-28       Impact factor: 4.096

6.  Epigenetic-Mediated Downregulation of μ-Protocadherin in Colorectal Tumours.

Authors:  Mateusz Bujko; Paulina Kober; Małgorzata Statkiewicz; Michal Mikula; Marcin Ligaj; Lech Zwierzchowski; Jerzy Ostrowski; Janusz Aleksander Siedlecki
Journal:  Gastroenterol Res Pract       Date:  2015-04-20       Impact factor: 2.260

Review 7.  Molecular and pathogenetic aspects of tumor budding in colorectal cancer.

Authors:  Heather Dawson; Alessandro Lugli
Journal:  Front Med (Lausanne)       Date:  2015-03-10

8.  Immature myeloid progenitors promote disease progression in a mouse model of Barrett's-like metaplasia.

Authors:  Jianping Kong; Hong Sai; Mary Ann S Crissey; Nirag Jhala; Gary W Falk; Gregory G Ginsberg; Julian A Abrams; Hiroshi Nakagawa; Kenneth Wang; Anil K Rustgi; Timothy C Wang; John P Lynch
Journal:  Oncotarget       Date:  2015-10-20

9.  Epigenetic silencing of the MUPCDH gene as a possible prognostic biomarker for cyst growth in ADPKD.

Authors:  Yu Mi Woo; Yubin Shin; Jung-Ah Hwang; Young-Hwan Hwang; Sunyoung Lee; Eun Young Park; Hyun Kyung Kong; Hayne Cho Park; Yeon-Su Lee; Jong Hoon Park
Journal:  Sci Rep       Date:  2015-10-14       Impact factor: 4.379

10.  Loss of Cdx2 Expression in Primary Tumors and Lymph Node Metastases is Specific for Mismatch Repair-Deficiency in Colorectal Cancer.

Authors:  Heather Dawson; Viktor H Koelzer; Anne C Lukesch; Makhmudbek Mallaev; Daniel Inderbitzin; Alessandro Lugli; Inti Zlobec
Journal:  Front Oncol       Date:  2013-10-11       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.